Liquidia Corp
(STU:LT4)
€
10.69
-0.02 (-0.18%)
Market Cap: 925.62 Mil
Enterprise Value: 734.65 Mil
PE Ratio: 0
PB Ratio: 8.84
GF Score: 66/100 Liquidia Corp at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 04:35PM GMT
Release Date Price:
€6.84
(+0.59%)
Gregory Allen Harrison
BofA Securities, Research Division - Analyst
Hello, everyone. Welcome to day 1 of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the Biotech Analysts here at Bank of America. And today, we have Liquidia Corporation, represented by Michael Kaseta, Chief Financial Officer. Thanks for joining us.
Michael Kaseta
Liquidia Corporation - CFO
Thanks for having me, Greg.
Gregory Allen Harrison
BofA Securities, Research Division - Analyst
Do you want to start off with maybe a quick opening remarks and then we'll jump into Q&A.
Michael Kaseta
Liquidia Corporation - CFO
Yes, that would be great. I mean, first of all, I just want to thank you for having us. It's really a great time for Liquidia. We think we're nearing the completion of our patent litigation with our competitor.
We are laser-focused on commercial readiness for launching YUTREPIA by the first half of 2024, if not earlier. And we're really excited to treat
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot